NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹1,883 Cr | ₹1,388 Cr | ₹715 Cr | ₹170 Cr | ₹442 Cr |
What is the latest Profit After Tax of NATCO PHARMA ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹1,883 Cr |
| Mar2024 | ₹1,388 Cr |
| Mar2023 | ₹715 Cr |
| Mar2022 | ₹170 Cr |
| Mar2021 | ₹442 Cr |
How is Profit After Tax of NATCO PHARMA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,883 Cr | 35.66 | |
| Mar2024 | ₹1,388 Cr | 94.09 | |
| Mar2023 | ₹715 Cr | 320.76 | |
| Mar2022 | ₹170 Cr | -61.57 | |
| Mar2021 | ₹442 Cr | - | |
Compare Profit After Tax of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹18,210.0 Cr | -13.1% | -7.1% | 33.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -13.1% |
-7.1% |
33.6% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses